Mitochondrial mechanisms in cerebral vascular control: Shared signaling pathways with preconditioning

Journal of Vascular Research

Volumn 51, Issue 3, 2014, Pages 175-189

  Busija, David W ^a   Katakam, Prasad V ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine triphosphate sensitive potassium channels; Anoxia; Calcium sparks; Cerebral arteries; Endothelium; Ischemia; Neurons; Nitric oxide synthase; Postconditioning; Vascular smooth muscle

Indexed keywords

REACTIVE OXYGEN METABOLITE; ADENOSINE TRIPHOSPHATE; POTASSIUM CHANNEL; PROTEIN KINASE;

BLOOD VESSEL TONE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; CELL MEMBRANE DEPOLARIZATION; HUMAN; INSULIN RESISTANCE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; STROKE PATIENT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION; BLOOD FLOW; BRAIN ARTERY; CEREBROVASCULAR ACCIDENT; DEPOLARIZATION; DIABETES MELLITUS; ENDOTHELIUM; MACROGLIA; MITOCHONDRIAL MEMBRANE; NERVE CELL; NEUROPROTECTION; SMOOTH MUSCLE;

BENZIMIDAZOLES; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERIES; ISCHEMIC PRECONDITIONING; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNELS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84901163498     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000360765     Document Type: Review

References (133)

1. Busija DW, Lacza Z, Rajapakse N, Shimizu K,Kis B, Bari F, Domoki F, Horiguchi T: Targetingmitochondrial ATP-sensitive potassiumchannels-A novel approach to neuroprotection. Brain Res Rev 2004; 46: 282-294.
2. Duckles SP, Krause DN: Cerebrovascular effectsof oestrogen: multiplicity of action. ClinExp Pharmacol Physiol 2007; 34: 801-808.
3. Katakam PVG, Gordon A, Venkata NLRS,Rutkai I, Busija DW: Diversity of mitochondrial-dependent dilator mechanisms in vascularsmooth muscle of cerebral arteries fromnormal and insulin resistant rats. Am J Physiol,in press.
4. McBride HM, Neuspiel M, Wasiak S: Mitochondria:more than just a powerhouse. CurrBiol 2006; 16:R551-R560.
5. Wappler EA, Institoris A, Dutta S, KatakamPV, Busija DW: Mitochondrial dynamics associatedwith oxygen-glucose deprivation inrat primary neuronal cultures. PLoS One2013; 8:e63206.
6. Halestrap AP: The mitochondrial permeabilitytransition: its molecular mechanism androle in reperfusion injury. Biochem Soc Symp1999; 66: 181-203.
7. Kubli DA, Gustafsson AB: Mitochondria andmitophagy: the yin and yang of cell death control. Circ Res 2012; 111: 1208-1221.
8. Dromparis P, Sutendra G, Michelakis ED: The role of mitochondria in pulmonary vascularremodeling. J Mol Med (Berl) 2010; 88:1003-1010.
9. Groschner LN, Waldeck-Weiermair M, MalliR, Graier WF: Endothelial mitochondria-less respiration, more integration. PflugersArch 2012; 464: 63-76.
10. Kluge MA, Fetterman JL, Vita JA: Mitochondriaand endothelial function. Circ Res 2013;12: 1171-1188.
11. Widlansky ME, Gutterman DD: Regulationof endothelial function by mitochondrial reactivespecies. Antioxid Redox Signal 2011; 15:1517-1530.
12. McCarron JG, Wilson C, Sandison ME, OlsonML, Girkin JM, Saunter C, Chalmers S: Fromstructure to function: mitochondrial morphology,motion and shaping in vascular smooth muscle. J Vasc Res 2013; 50: 357-371.
13. Jonckheere AI, Smeitink JA, Rodenburg RJ:Mitochondrial ATP synthase: architecture,function and pathology. J Inherit Metab Dis2012; 35: 211-225.
14. Davidson SM: Endothelial mitochondria andheart disease. Cardiovasc Res 2010; 88: 58-66.
15. Graham D, Huynh NN, Hamilton CA, BeattieE, Smith RA, Cocheme HM, Murphy MP,Dominiczak AF: Mitochondria-targeted antioxidantMitoQ10 improves endothelial functionand attenuates cardiac hypertrophy. Hypertension2009; 54: 322-328.
16. Kalyanaraman B: Oxidative chemistry of fluorescentdyes: implications in the detection ofreactive oxygen and nitrogen species. BiochemSoc Trans 2011; 39: 1221-1225.
17. Nishikawa T, Edelstein D, Du XL, YamagishiS, Matsumura T, Kaneda Y, Yorek MA, BeebeD, Oates PJ, Hammes HP, Giardino I, BrownleeM: Normalizing mitochondrial superoxideproduction blocks three pathways of hyperglycaemicdamage. Nature 2000; 404: 787-790.
18. Drose S, Brandt U: Molecular mechanisms ofsuperoxide production by the mitochondrialrespiratory chain. Adv Exp Med Biol 2012;748: 145-169.
19. Walker JE: The ATP synthase: the understood,the uncertain and the unknown. BiochemSoc Trans 2013; 41: 1-16.
20. Dorn GW, Scorrano L: Two close, too close:sarcoplasmic reticulum-mitochondrial crosstalkand cardiomyocyte fate. Circ Res 2010;107: 689-699.
21. Duckles SP, Krause DN: Mechanisms of cerebrovascularprotection: oestrogen, inflammationand mitochondria. Acta Physiol 2011;203: 149-154.
22. Zick M, Rabl R, Reichert AS: Cristae formation-linking ultrastructure and function ofmitochondria. Biochim Biophys Acta 2008;1793: 5-19.
23. Hill BG, Benavides GA, Lancaster JR Jr, BallingerS, Dell'Italia L, Jianhua Z, Darley-UsmarVM: Integration of cellular bioenergeticswith mitochondrial quality control and autophagy. Biol Chem 2012; 93: 1485-1512.
24. Chalmers S, Saunter C , Wilson C, Coats P Girkin JM, McCarron JG: Mitochondrial motilityand vascular smooth muscle proliferation. Arterioscler Thromb Vasc Biol 2012; 32:3000-3011.
25. Chalmers S, Olson ML, MacMillan D, RainbowRD, McCarron JG: Ion channels insmooth muscle: regulation by the sarcoplasmicreticulum and mitochondria. Cell Calcium2007; 42: 447-466.
26. Dai J, Kuo KH, Leo JM, van Breemen C, LeeCH: Rearrangement of the close contact betweenthe mitochondria and the sarcoplasmicreticulum in airway smooth muscle. Cell Calcium2005; 37: 333-340.
27. Daiber A: Redox signaling (cross-talk) fromand to mitochondria involves mitochondrialpores and reactive oxygen species. BiochimBiophys Acta 2010; 1797: 897-906.
28. Ghezzi D, Zeviani M: Assembly factors of humanmitochondrial respiratory chain complexes:physiology and pathophysiology. AdvExp Med Biol 2012; 748: 65-106.
29. Lenaz G, Genova ML: Structure and organizationof mitochondrial respiratory complexes:A new understanding of an old subject. AntioxidRedox Signal 2010; 12: 961-1008.
30. Lacza Z, Snipes JA, Zhang J, Horvath EM, FigureroaJP, Szabo C, Busija DW: Lack of mitochondrialnitric oxide production in thebrain. J Neurochem 2004; 90: 942-951.
31. Lacza Z, Pankotai E, Csordas A, Gero D, KissL, Horvath EM, Kollai M, Busija DW, SzaboC: Mitochondrial NO and reactive nitrogenspecies production: does mtNOS exist? NitricOxide 2006; 14: 162-168.
32. Katakam PV, Wappler E, Katz P, Rutkai I, InstitorisA, Domoki F, Gaspar T, GrovenburgSM, Snipes JA, Busija DW: Depolarization ofmitochondria in endothelial cells promotescerebral vascular vasodilation by activation ofnitric oxide synthase. Arterioscler ThrombVasc Biol 2013; 33: 752-759.
33. Meng W, Tobin JR, Busija DW: Glutamateinducedcerebral vasodilation is mediated bynitric oxide through N-methyl-D-Aspartatereceptors. Stroke 1995; 26: 857-862.
34. Lacza Z, Kozlov AV, Pankotai E, Csordas A,Wolf G, Redl H, Kollai M, Szbo C, Busija DW,Horn TFW: Mitochondria produce reactivenitrogen species via an arginine-independentpathway. Free Radic Res 2006; 40: 369-378.
35. Forstermann U: Nitric oxide and oxidativestress in vascular disease. Pflugers Arch 2010;459: 923-939.
36. Gaspar T, Snipes JA, Busija AR, Kis B, DomokiF, Bari F, Busija DW: ROS-independentpreconditioning in neurons via activation ofmitoK ATP channels by BMS-191095. J CerebBlood Flow Metab 2008; 28: 1090-1103.
37. Rajapakse N, Kis B, Horiguchi T, Snipes J, BusijaD: Diazoxide pretreatment induces delayedpreconditioning in astrocytes against oxygenglucose deprivation and hydrogen peroxide-inducedtoxicity. J Neurosci Res 2003; 73: 206-214.
38. Han D, William E, Cadenas E: Mitochondrialrespiratory chain-dependent generation of superoxideanion and its release into the intermembranespace. Biochem J 2001; 353: 411-416.
39. Yang W, Hekimi S: A mitochondrial superoxidesignal triggers increased longevity inCaenorhabditis elegans . PLoS Biol 2010; 8:e1000556.
40. Votyakova TV, Reynolds IJ: DeltaPsi(m)-dependentand-independent production of reactiveoxygen species by rat brain mitochondria. J Neurochem 2001; 79: 266-277.
41. Wojtovich AP, Smith CO, Haynes CM, NehrkeKW, Brookes PS: Physiological consequencesof complex II inhibition for aging,disease, and the mK ATP channel. BiochimBiophys Acta 2013; 1827: 598-611.
42. Muller FL, Liu Y, Van Remmem H: ComplexIII releases superoxide to both sides of the innermitochondrial membrane. J Biol Chem2004; 279: 49064-49073.
43. Jastroch M, Divakaruni AS, Mookerjee S, TrebergJR, Brand MD: Mitochondrial proton andelectron leaks. Essays Biochem 2010; 47: 53-67.
44. Bienert GP, Moller AL, Kristiansen KA,Schulz A, Moller IM, Schjoerring JK, Jahn TP:Specific aquaporins facilitate the diffusion ofhydrogen peroxide across membranes. J BiolChem 2007; 282: 1183-1192.
45. Calamita G, Ferri D, Gena P, Liquori GE, CavalierA, Thomas D, Svelto M: The inner mitochondrialmembrane has aquaporin-8 waterchannels and is highly permeable to water. JBiol Chem 2005; 280: 17149-17153.
46. Marchissio MJ, Frances DE, Carnovale CE,Marinelli RA: Mitochondrial aquaporin-8knockdown in human hepatoma HepG2 cellscauses ROS-induced mitochondrial depolarizationand loss of viability. Toxicol ApplPharmacol 2012; 64: 246-254.
47. Quinlan CL, Perevoschikova IV, GoncalvesRL, Hey-Mogensen M, Brand MD: The determinationand analysis of site-specific rates ofmitochondrial reactive oxygen species production. Methods Enzymol 2013; 526: 189-217.
48. Zhang DX, Gutterman DD: Mitochondrialreactive oxygen species-mediated signaling inendothelial cells. Am J Physiol Heart CircPhysiol 2007; 292:H2023-H2031.
49. Rajapakse N, Shimizu K, Snipes J, Lacza Z,Busija D: Activation of mitochondrial ATPsensitivepotassium channels prevents neuronalcell death after ischemia in neonatal rats. Neurosci Lett 2002; 327: 208-212.
50. Lu B, Poirier C, Gaspar T, Gratzke C, HarrisonW, Busija D, Matsuk M, Andersson KE,Overbeek PA, Bishop CE: A mutation in theinner mitochondrial membrane peptidase2-like gene (Immp2l) affects mitochondrialfunction and impairs fertility in mice. Biol Reprod2008; 78: 601-610.
51. Katakam PV, Jordan JE, Snipes JA, TulbertCD, Miller AW, Busija DW: Myocardial preconditioningagainst ischemia-reperfusion isabolished in Zucker obese rats with insulin. Am J Physiol Regul Integr Comp Physiol2007; 292:R920-R926.
52. Katakam PV, Domoki F, Snipes JA, BusijaAR, Jarajapu YP, Busija DW: Impaired mitochondria-dependent vasodilation in cerebralarteries of Zucker obese rats with insulin resistance. Am J Physiol Regul Integr CompPhysiol 2009; 296:R289-R298.
53. Brown KA, Didion SP, Andresen JJ, Faraci FM:Effects of aging, MnSOD deficiency, and geneticbackground on endothelial function: evidencefor MnSOD haploinsufficiency. ArteriosclerThromb Vasc Biol 2007; 27: 1941-1946.
54. Pung YF, Sam WJ, Hardwick JP, Yin L, OhanyanV, Logan S, Di Vincenzo L, Chilian WM: The role of mitochondrial bioenergetics andreactive oxygen species in coronary collateralgrowth. Am J Physiol Heart Circ Physiol2013; 305:H1275-H1280.
55. Han D, Antunes F, Canali R, Rettori D, CadenasE: Voltage-dependent anion channelscontrol the release of the superoxide anionfrom mitochondria to cytosol. J Biol Chem2003; 278: 5557-5563.
56. Dikalova AE, Bikineyeva AT, Budzyn K, NazarewiczRR, McCann L, Lewis W, HarrisonDG, Dikalov SI: Therapeutic targeting of mitochondrialsuperoxide in hypertension. CircRes 2010; 107: 106-116.
57. Zinkevich NS, Gutterman DD: ROS-inducedROS release in vascular biology: redox-redoxsignaling. Am J Physiol Heart Circ Physiol2011; 301:H647-H653.
58. Nazarewicz RR, Dikalova AE, Bikineyeva A,Dikalov SI: Nox2 as a potential target of mitochondrialsuperoxide and its role in endothelialoxidative stress. Am J Physiol Heart CircPhysiol 2013; 305:H1131-H1140.
59. Chrissobolis S, Faraci FM: Sex differences inprotection against angiotensin II-induced endothelialdysfunction by manganese superoxidedismutase in the cerebral circulation. Hypertension2010; 55: 905-910.
60. Miller JD, Peotta VA, Chu Y, Weiss RM, ZimmermanK, Brooks RM, Heistad DD: MnSODprotects against COX1-mediated endothelialdysfunction in chronic heart failure. Am JPhysiol Heart Circ Physiol 2010; 298:H1600-H1607.
61. Ardehali H, O'Rourke B: MitochondrialK(ATP) channels in cell survival and death. JMol Cell Cardiol 2005; 39: 7-163.
62. Foster DB, Ho AS, Rucker J, Garlid AO, ChenL, Sidor A, Garlid KD, O'Rourke B: MitochondrialROMK channel is a molecularcomponent of mitoK(ATP). Circ Res 2012;111: 446-454.
63. Seharaseyon J, Ohler A, Sasaki N, Fraser H,Sato T, Johns DC, O'Rourke B, Marban E:Molecular composition of mitochondrialATP-sensitive potassium channels probed byviral Kir gene transfer. J Mol Cell Cardiol2000; 32: 1923-1930.
64. Lacza Z, Snipes JA, Kis B, Szabo C, Grover G,Busija DW: Investigation of the subunit compositionand the pharmacology of the mitochondrialATP-dependent K + channel in thebrain. Brain Res 2003; 19: 27-36.
65. Lacza Z, Snipes JA, Miller AW, Czabo C, GroverG, Busija DW: Heart mitochondria containfunctional ATP-dependent K + channels. J Mol Cell Cardiol 2003; 35: 1339-1347.
66. Rines AK, Bayeva M, Ardehali H: A newpROM king for the mitoK ATP dance: ROMKtakes the lead. Circ Res 2012; 111: 392-393.
67. Wojtovich AP, Smith CO, Haynes CM, NehrkeKW, Brookes PS: Physiological consequencesof complex II inhibition for aging,disease, and the mK ATP channel. BiochimBiophys Acta 2013; 1827: 598-611.
68. Perez-Pinzon MA, Dave KR, Raval AP: Roleof reactive oxygen species and protein kinaseC in ischemic tolerance in the brain. AntioxidRedox Signal 2005; 7: 1150-1157.
69. Perez-Pinzon MA: Mechanisms of neuroprotectionduring ischemic preconditioning: lessonsfrom anoxic tolerance. Comp BiochemPhysiol 2007; 147: 291-299.
70. Hanley PJ, Gopalan KV, Lareau RA, et al: Betaoxidationof 5-hydroxydecanoate, a putativeblocker of mitochondrial ATP-sensitive potassiumchannels. J Physiol 2003; 547: 387-393.
71. Busija DW, Katakam P, Rajapakse NC, Kis B,Grover G, Domoki F, Bari F: Effects of ATPsensitivepotassium channel activators diazoxideand BMS-191095 on membrane potentialand reactive oxygen species productionin isolated piglet mitochondria. BrainRes Bull 2005; 66: 85-90.
72. Farkas E, Domoki F, Institoris A, et al: Neuroprotectionby diazoxide in animal modelsfor cerebrovascular disorders. Vasc Dis Prev2006; 3: 253-263.
73. Coetzee WA: Multiplicity of effectors of thecardioprotective agent, diazoxide. PharmacolTher 2013; 140: 167-175.
74. Kis B, Rajapakse N, Snipes JA, Nagy K, HoriguchiT, Busija DW: Diazoxide induces delayedpreconditioning in cultured rat corticalneurons. J Neurochem 2003; 87: 969-980.
75. Lenzser G, Kis B, Bari F, Busija DW: Diazoxidepreconditioning attenuates global cerebralischemia-induced blood-brain barrierpermeability. Brain Res 2005; 105: 72-80.
76. Busija DW, Gaspar T, Domoki F, KatakamPV, Bari F: Mitochondrial-mediated suppressionof ROS production upon exposure ofneurons to lethal stress: mitochondrial targetedpreconditioning. Adv Drug Deliv Rev2008; 16: 1471-1477.
77. Horiguchi T, Kis B, Rajapakse N, Shimizu K,Busija DW: Opening of mitochondrial ATPsensitivepotassium channels is a trigger of3-nitropropionic acid-induced tolerance totransient focal cerebral ischemia in rats. Stroke 2003; 34: 1015-1020.
78. Grover GJ, Burkett DE, Parham CS, ScaleseRJ, Sadanaga KK: Protective effect of mitochondrialK ATP activation in an isolated gracilismodel of ischemia and reperfusion indogs. J Cardiovasc Pharmacol 2003; 42: 790-792.
79. Grover GJ, Burkett DE, Parham CS, Scalese RJ,Sadanaga KK: Protective effect of mitochondrialK ATP activation in an isolated gracilismodel of ischemia and reperfusion in dogs. JCardiovasc Pharmacol 2003; 42: 790-792.
80. Bednarczyk P, Koziel A, Jarmuszkiewicz W,Szewczyk A: Large-conductance Ca 2+-Activatedpotassium channel in mitochondria ofendothelial EA. hy926 cells. Am J PhysiolHeart Circ Physiol 2013; 304:H1415-H1427.
81. Gaspar T, Katakam P, Snipes JA, Kis B,Domoki F, Bari F, Busija DW: Delayed neuronalpreconditioning by NS1619 is independentof calcium activated potassium channels. J Neurochem 2008; 105: 1115-1128.
82. Gaspar T, Domoki F, Lenti L, Katakam PVG,Snipes JA, Bari F, Busija DW: Immediate neuronalpreconditioning with NS1619. BrainRes 2009; 1285: 196-207.
83. Tretter L, Adam-Vizi V: Uncoupling withoutan effect on the production of reactive oxygenspecies by in situ synaptic mitochondria. JNeurochem 2007; 103: 1864-1871.
84. Domoki F, Kis B, Gaspar T, Snipes JA, Bari F,Busija DW: Rosuvastatin induces delayedpreconditioning against oxygen-glucose deprivationin cultured cortical neurons. Am JPhysiol 2009; 296:C97-C105.
85. Domoki F, Perciaccante JV, Veltkamp R, BariF, Busija DW: Mitochondrial potassiumchannel opener diazoxide preserves neuronal-vascular function after cerebral ischemiain newborn pigs. Stroke 1999; 30: 2713-2718.
86. Domoki F, Bari F, Nagy K, Busija DW, SiklosL: Diazoxide prevents mitochondrial swellingand Ca 2+ accumulation in CA1 pyramidalcells after cerebral ischemia in newborn pigs. Brain Res 2004; 1019: 97-104.
87. Gaspar T, Kis B, Snipes JA, Lenzser G, MayanagiK, Bari F, Busija DW: Neuronal preconditioningwith the antianginal drug, bepridil. J Neurochem 2007; 102: 595-608.
88. Horiguchi T, Snipes JA, Kis B, Shimizu S,Busija DW: The role of nitric oxide in the developmentof cortical spreading depressioninducedtolerance to transient focal cerebralischemia in rats. Brain Res 2005; 1039: 84-89.
89. Horiguchi T, Kis B, Rajapakse N, Shimizu K,Busija DW: Cortical spreading depression(CSD)-induced tolerance to transient focalcerebral ischemia in halothane anesthetizedrats is affected by anesthetic level but notATP-sensitive potassium channels. Brain Res2005; 1062: 127-133.
90. Loukogeorgakis SP, Williams R, PanagiotidouAT, Kolvekar SK, Donald A, Cole TJ, YellonDM, Deanfield JE, MacAllister RJ: Transientlimb ischemia induces remote preconditioningand remote postconditioning in humansby a K(ATP)-channel dependent mechanism. Circulation 2007; 116: 1386-1395.
91. Mayanagi K, Gaspar T, Katakam PV, Kis B,Busija DW: The mitochondrial K(ATP) channelopener BMS-191095 reduces neuronaldamage after transient focal cerebral ischemiain rats. J Cereb Blood Flow Metab 2007; 27:348-355.
92. McIntosh VJ, Lasley RD: Adenosine receptormediatedcardioprotection: are all 4 subtypesrequired or redundant? J Cardiovasc PharmacolTher 2012; 17: 21-33.
93. Robin E, Simerabet M, Hassoun SM, AdamczykS, Tavernier B, Vallet B, Bordet R, LebuffeG: Postconditioning in focal cerebral ischemia:role of the mitochondrial ATP-dependentpotassium channel. Brain Res 2011; 1375:137-146.
94. Shimizu K, Lacza Z, Rajapakse N, HoriguchiT, Snipes J, Busija DW: MitoK ATP opener,diazoxide, reduces neuronal damage aftermiddle cerebral artery occlusion in the rat. Am J Physiol Heart Circ Physiol 2002; 283:H1005-H1011.
95. Broadhead MW, Kharbanda RK, Peters MJ,MacAllister RJ: K ATP channel activation inducesischemic preconditioning of the endotheliumin humans in vivo. Circulation2004; 110: 2077-2082.
96. Gidday JM: Cerebral preconditioning andischaemic tolerance. Nat Rev Neurosci 2006;7: 437-448.
97. Kirino T: Ischemic tolerance. J Cereb BloodFlow Metab 2002; 22: 1283-1296.
98. Zhao H: Ischemic postconditioning as anovel avenue to protect against brain injuryafter stroke. J Cereb Blood Flow Metab 2009;29: 873-885.
99. Levin SG, Godukhin OV: Comparative rolesof ATP-sensitive K + channels and Ca 2+-ActivatedBK + channels in posthypoxic hyperexcitabilityand rapid hypoxic preconditioningin hippocampal CA1 pyramidal neurons invitro. Neurosci Lett 2009; 461: 90-94.
100. Debska G, Kicinska A, Dobrucki J, DworakowskaB, Nurowska E, Skalska J, Dolowy K,Szewczyk A: Large-conductance K + channelopeners NS1619 and NS004 as inhibitors ofmitochondrial function in glioma cells. BiochemPharmacol 2003; 65: 1827-1834.
101. Veltkamp R, Domoki F, Bari F, Busija DW:Potassium channel activators protect theNMDA-induced cerebral vascular dilationafter combined hypoxia and ischemia in piglets. Stroke 1998; 29: 837-843.
102. Bari F, Louis TM, Busija DW: Calcium-ActivatedK + channels in cerebral arterioles inpiglets are resistant to ischemia. J CerebBlood Flow Metab 1997; 17: 1152-1156.
103. Kicinska A, Szewczyk A: Large-conductancepotassium cation channel opener NS1619inhibits cardiac mitochondria respiratorychain. Toxicol Mech Methods 2004; 14: 59-61.
104. Korper S, Nolte F, Rojewski MT, Thiel E,Schrezenmeier H: The K + channel openersdiazoxide and NS1619 induce depolarizationof mitochondria and have differentialeffects on cell Ca 2+ in CD34+ cell line KG-1a. Exp Hematol 2003; 31: 815-823.
105. Harrell JW, Morgan BJ, Schrage WG: Impairedhypoxic cerebral vasodilation inyounger adults with metabolic syndrome. Diab Vasc Dis Res 2013; 10: 135-142.
106. Gaspar T, Kis B, Snipes J, Lenzser G, MayanagiK, Bari F, Busija D: Transient glucoseand amino acid deprivation induces delayedpreconditioning in cultured rat cortical neurons. J Neurochem 2006; 98: 555-565.
107. Pelligrino DA, Vetri F, Xu HL: Purinergicmechanisms in gliovascular coupling. SeminCell Dev Biol 2011; 22: 229-236.
108. You J, Johnson TD, Marrelli SP, Bryan RM Jr:Functional heterogeneity of endothelial P2purinoceptors in the cerebrovascular tree ofthe rat. Am J Physiol 1999; 277:H893-H900.
109. Auchampach JA, Gross GJ: Adenosine A1receptors, K ATP channels, and ischemic preconditioningin dogs. Am J Physiol 1993;264:H1327-H1336.
110. Dietrich HH, Horiuchi T, Xiang C, HongoK, Falck JR, Dacey RG Jr: Mechanism ofATP-induced local and conducted vasomotorresponses in isolated rat cerebral penetratingarterioles. J Vasc Res 2009; 46: 253-264.
111. Xi Q, Cheranov SY, Jaggar JH: Mitochondria-derived reactive oxygen species dilatecerebral arteries by activating Ca 2+ sparks. Circ Res 2005; 97: 354-362 .
112. Kemper MF, Zhao Y, Duckles SP, KrauseDN: Endogenous ovarian hormones affectmitochondrial efficiency in cerebral endotheliumvia distinct regulation of PGC-1 isoforms. J Cereb Blood Flow Metab 2013; 33:122-128.
113. Cheranov SY, Jaggar JH: Mitochondrialmodulation of Ca 2+ sparks and transient K Cacurrents in smooth muscle cells of rat cerebralarteries. J Physiol 2004; 556: 755-771.
114. Oldendorf WH, Cornford ME, Brown WJ: The large apparent work capacity of theblood-brain barrier: a study of the mitochondrialcontent of capillary endothelialcells in brain and other tissues of the rat. AnnNeurol 1977; 1: 409-417.
115. Koller A, Toth P: Contribution of flow-dependentvasomotor mechanisms to the autoregulationof cerebral blood flow. J VascRes 2012; 49: 375-389.
116. Behringer EJ: Aging impairs electrical conductionalong endothelium of resistance artriesthrough enhanced Ca 2+-Activated K +channel activation.Artrioscler ThrombVasc Biol 2013; 33: 1892-1901.
117. Razmara A, Sunday L, Stirone C, Wang XB,Krause DN, Duckles SP, Procaccio V: Mitochondrialeffects of estrogen are mediated byestrogen receptor alpha in brain endothelialcells. J Pharmacol Exp Ther 2008; 325: 782-790.
118. Busija DW, Heistad DD: Factors involved inthe physiological regulation of the cerebralcirculation. Rev Physiol Biochem Pharmacol1984; 101: 161-211.
119. Dauphin F, MacKenzie ET: Cholinergic andvasoactive intestinal polypeptidergic innervationof the cerebral arteries. PharmacolTher 1995; 67: 385-417.
120. Toda N, Okamura T: Nitroxidergic nerve:regulation of vascular tone and blood flow inthe brain. J Hypertens 1996; 14: 423-434.
121. Katakam PVG, Wappler E, Dutta S, BusijaDW: Mitochondria-dependent cerebral arteryvasodilation is mediated by the activationof neuronal nitric oxide synthase followingmitochondrial depolarization ofperivascular nerves (abstract). FASEB J2012; 26: 1058-1059.
122. Ayajiki K, Tanaka T, Okamura T, Toda N:Evidence for nitroxidergic innervation inmonkey ophthalmic arteries in vivo and invitro. Am J Physiol 2000; 279:H2006-H2012.
123. Jiang K, Wang J, Zhao C, Feng M, Shen Z,Yu Z, Xia Z: Regulation of gap junctionalcommunication by astrocytic mitochondrialK(ATP) channels following neurotoxin administrationin in vitro and in vivo models. Neurosignals 2011; 19: 63-74.
124. Kis B, Nagy K, Snipes JA, Rajapakse N, HoriguchiT, Grover GJ, Busija DW: The mitochondrialK ATP channel opener BMS191095induces neuronal preconditioning. Neuroreport2004; 15: 345-349.
125. Kizhakekuttu TJ, Wang J, DharmashankarK, Ying R, Gutterman DD, Vita JA, WidlanskyME: Adverse alterations in mitochondrialfunction contribute to type 2 diabetesmellitus-related endothelial dysfunction inhumans. Arterioscler Thromb Vasc Biol2012; 32: 2531-2539.
126. Erdos B, Snipes JA, Miller AW, Busija DW:Cerebrovascular dysfunction in Zuckerobese rats is mediated by oxidative stress andprotein kinase C. Diabetes 2004; 53: 1352-1359.
127. Erdos B, Simandle SA, Snipes JA, MillerAW, Busija DW: Potassium channel dysfunctionin cerebral arteries of insulin-resistantrats is mediated by reactive oxygen species. Stroke 2004; 35: 964-969.
128. Erdos B, Snipes JA, Tulbert C, Katakam P,Miller AW, Busija DW: Rosuvastatin improvescerebrovascular function in Zuckerobese rats by inhibiting NAD(P)H-oxidasedependentsuperoxide anion production. Am J Physiol Heart Circ Physiol 2006; 290:H1264-H1270.
129. Bari F, Louis TM, Meng W, Busija DW:Global ischemia impairs ATP-sensitive K +channel function in cerebral arterioles inpiglets. Stroke 1996; 27: 1874-1881.
130. Mayanagi K, Katakam PV, Gaspar T, DomokiF, Busija DW: Acute treatment with rosuvastatinprotects insulin resistant (C57BL/6Job/ob) mice against transient cerebral ischemia. J Cerebral Blood Flow Metab 2008; 28:1927-1935.
131. Makino A, Scott BT, Dillmann WH: Mitochondrialfragmentation and superoxide anionproduction in coronary endothelial cellsfrom a mouse model of type 1 diabetes. Diabetologia2010; 53: 1783-1794.
132. Domoki F, Kis B, Nagy K, Farkas E, BusijaDW, Bari F: Diazoxide preserves hypercapnia-induced arteriolar vasodilation afterglobal cerebral ischemia in piglets. Am JPhysiol 2005; 289:H368-H373.
133. Rutkai I, Dutta S, Liu D, Katakam PVG,Busija DW: Enhanced cerebrovascular responseto mitochondrial depolarization followingmiddle cerebral artery occlusion. SocNeurosci Abstr 2013; 144. 05-L6. Health